Corrigendum: Decreased Risk of Anxiety in Diabetic Patients Receiving Glucagon-Like Peptide-1 Receptor Agonist: A Nationwide, Population-Based Cohort Study

• Wen-Hsuan Tsai,
• Fung-Chang Sung,
• Fung-Chang Sung,
• Fung-Chang Sung,
• Lu-Ting Chiu,
• Ying-Hsiu Shih,
• Ming-Chieh Tsai,
• Shu-I Wu,
• Shu-I Wu

Affiliations

Wen-Hsuan Tsai

Division of Endocrinology and Metabolism, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan

Fung-Chang Sung

Management Office for Health Data (DryLab), Clinical Trial Research Center (CTC), China Medical University Hospital, Taipei, Taiwan

Fung-Chang Sung

Department of Health Services Administration, China Medical University, College of Public Health, Taichung, Taiwan

Fung-Chang Sung

Department of Food Nutrition and Health Biotechnology, Asia University, Taichung, Taiwan

Lu-Ting Chiu

Management Office for Health Data (DryLab), Clinical Trial Research Center (CTC), China Medical University Hospital, Taipei, Taiwan

Ying-Hsiu Shih

Management Office for Health Data (DryLab), Clinical Trial Research Center (CTC), China Medical University Hospital, Taipei, Taiwan

Ming-Chieh Tsai

Division of Endocrinology and Metabolism, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan

Shu-I Wu

Department of Medicine, Mackay Medical College, New Taipei City, Taiwan

Shu-I Wu

Department of Psychiatry, Mackay Memorial Hospital, Taipei, Taiwan